Tag: COVID-19
-
UPDATE: Indian Company ready to launch Oral drug to treat COVID-19
Glenmark Pharma (Glenmark Pharmaceuticals) may have become the first Indian company to market a COVID-19 control drug. It received clearance from the government’s drug regulator to market and manufacturer an oral drug that will treat mild to moderate levels of the virus in Covid-19 disease. However, the government officials and industry watchdogs have also ... -
Veerappa Moily slams centre for sadistically hiking fuel prices amidst COVID-19
On Monday, Senior Congress leader, Veerappa Moily slammed centre for hiking the fuel prices at frequent intervals. He accused the BJP-led government of fleecing the people especially at the distressing time of COVID-19 pandemic. Former Petroleum minister’s statement critical of the government’s price rise policy came on the day, when petrol pricesrose by 33 paise ... -
Patanjali claims to have found coronavirus cure
Baba Ramdev says the drug has been clinically tested and is shown to have cured 100% of the subjects in seven days. Godman, yoga master and founder of the Patanjali brand Baba Ramdev launched an Ayurvedic made-in-India drug kit that purportedly cures coronavirus within a week. It’s not an immunity booster like the ones they ... -
Indian stars come together for ‘Play for India’ initiative to help sports community
“Play for India” initiative launch was encouraged by the biggest names in Indian sports fraternity who came together to support it. The initiative is aimed at assisting individuals associated with Indian sports who have been hard hit by the COVID-19 induced nationwide lockdown leading to non-operational stadia and sports complexes. The support staff at the ... -
Indian company ready to launch oral drug to treat COVID-19
Glenmark Pharma has become the first Indian company to have received clearance from the government’s drug regulator to market and manufacturer an oral drug that will treat mild to moderate levels of the virus in COVID-19 disease. The anti viral drug is called Favipiravir and will be marketed by the name Fabiflu that will be ... -
India China border tension May slow down Domestic manufacturing
According to industry experts, the recent unpleasantness between the Chinese and Indian armed forces is going to have a heavy impact on the Indian manufacturing industry. This is primarily because the tension escalated on the border has led to obvious trade restrictions as well. Experts are of the opinion that this escalating is a ploy ... -
PM Modi holds 2-day virtual meet with chief ministers for ground report on COVID-19 situation
In view of the rising Coronavirus infections across India, Prime Minister Narendra Modi on June 16 held the first round of two-day video conference with chief ministers of the states. Reportedly, PM Modi’s meeting with the chief minister will take place on June 16 and June 17, for which the states and Union Territories have ... -
India’s COVID-19 recovery rate improves to 52%
Even as the number of coronavirus cases is increasing steeply, more people are recovering. The recovery rate for coronavirus cases in the country has been improving steadily since April 15 when it stood at 11.42%. Slowly it climbed to 38.73% by May 19, breaching the 40% milestone two days later. It further improved to 48.19% ... -
With rising cases, Delhi is failing its COVID-19 patients
Delhi is one of the worst coronavirus-affected states in the country and its hospitals are buckling under the strain. Delhi was among the four states pulled up by the Supreme Court on the condition of hospitals for COVID-19 patients on the basis of media reports. Seeking a detailed status report, the court admonished the states ... -
How the economy can recover by the End of 2020
According to Chief Economic Advisor Krishnamurthy Subramanian, the Indian economy will take almost the second half of this year to recover from the lockdown hit slowing down of the economy. India is one of the fifth worst hit countries in the world with the COVID-19 disease. Mr. Subramanian has also indicated that it might take ...